CA
NZ
UK
AU
IND
US
With shares down 97.2% year-to-date, the microcap biotech is advancing its clinical program despite significant market skepticism.
LataMed AI Corp. has completed a forward stock split, a move designed to enhance share liquidity as the company accelerates its telehealth and artificial intelligence initiatives across Latin America. The split became effective at the opening of trading in mid‑July 2026, following publication on …
Mobia Medical has enhanced its governance by appointing a veteran medical technology leader to its board. The company, which specializes in minimally invasive surgical devices, welcomed Reza Zadno as an independent director. This addition increases the board’s size and brings expertise in surgical robotics …
Intuitive Surgical delivered a stronger-than-expected quarter, reporting earnings per share of $2.50 that surpassed the $2.14 consensus estimate. The beat comes as BMO Capital initiated coverage with an Outperform rating and a $518 price target, sending shares up 2.9% in recent trading.
Ensysce Biosciences (NASDAQ: ENSC) has announced another change in its leadership team, continuing a pattern of executive transitions at the micro-cap biotechnology firm. The departure, disclosed through a recent regulatory filing, reflects ongoing shifts in the company's management structure as it navigates the challenges …
Erasca Inc. (NASDAQ: ERAS) witnessed its share price jump 8.9% to $19.50 after a Phase 1 investigation of its ERAS‑0015 candidate reported a 57% shrinkage of pancreatic tumors. The company posted a loss per share that fell short of analyst expectations for the most …
The clinical research sector is undergoing a significant transformation as the Association of Clinical Research Professionals (ACRP) updates its certification programs to align with the ICH E6(R3) global standards. This change will affect thousands of professionals and reshape how clinical trials are planned, monitored, …
Inotiv (NASDAQ: NOTVQ) saw its prepackaged Chapter 11 plan confirmed on July 14, 2026, sealing the fate of its existing equity. The court order mandates the cancellation of every outstanding common share, 35,172,908 in total, leaving current shareholders with no residual value. In exchange, …
Dyne Therapeutics has locked in $125 million in non-dilutive capital, a move that analysts say extends its runway while advancing treatments for rare neuromuscular diseases. The biotech’s shares, up 31.1% in the past month, edged 0.3% higher to $23.84 in recent trading, reflecting investor …
Veritas Association Management has secured a notable industry distinction, earning AMC Institute Accreditation and joining a limited number of firms globally that meet the organization’s rigorous criteria. The accreditation, granted July 15, 2026, reflects elevated operational and financial standards for association management, particularly in …
Please wait processing your request...